• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再生心脏:一种旨在对整个心脏器官进行保守去细胞化处理的省时、低浓度、基于去污剂的方法。

RegenHeart: A Time-Effective, Low-Concentration, Detergent-Based Method Aiming for Conservative Decellularization of the Whole Heart Organ.

作者信息

Dal Sasso Eleonora, Menabò Roberta, Agrillo Davide, Arrigoni Giorgio, Franchin Cinzia, Giraudo Chiara, Filippi Andrea, Borile Giulia, Ascione Guido, Zanella Fabio, Fabozzo Assunta, Motta Raffaella, Romanato Filippo, Di Lisa Fabio, Iop Laura, Gerosa Gino

机构信息

Cardiovascular Regenerative Medicine, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua, Padua 35128, Italy.

Institute of Neuroscience, National Research Council (CNR), Padua 35127, Italy.

出版信息

ACS Biomater Sci Eng. 2020 Oct 12;6(10):5493-5506. doi: 10.1021/acsbiomaterials.0c00540. Epub 2020 Sep 10.

DOI:10.1021/acsbiomaterials.0c00540
PMID:33320567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8011801/
Abstract

Heart failure is the worst outcome of all cardiovascular diseases and still represents nowadays the leading cause of mortality with no effective clinical treatments, apart from organ transplantation with allogeneic or artificial substitutes. Although applied as the gold standard, allogeneic heart transplantation cannot be considered a permanent clinical answer because of several drawbacks, as the side effects of administered immunosuppressive therapies. For the increasing number of heart failure patients, a biological cardiac substitute based on a decellularized organ and autologous cells might be the lifelong, biocompatible solution free from the need for immunosuppression regimen. A novel decellularization method is here proposed and tested on rat hearts in order to reduce the concentration and incubation time with cytotoxic detergents needed to render acellular these organs. By protease inhibition, antioxidation, and excitation-contraction uncoupling in simultaneous perfusion/submersion modality, a strongly limited exposure to detergents was sufficient to generate very well-preserved acellular hearts with unaltered extracellular matrix macro- and microarchitecture, as well as bioactivity.

摘要

心力衰竭是所有心血管疾病中最严重的后果,如今仍是主要的死亡原因,除了使用同种异体或人工替代品进行器官移植外,尚无有效的临床治疗方法。尽管同种异体心脏移植被用作金标准,但由于存在一些缺点,如免疫抑制疗法的副作用,它不能被视为永久性的临床解决方案。对于越来越多的心力衰竭患者来说,一种基于去细胞化器官和自体细胞的生物心脏替代品可能是无需免疫抑制方案的终身生物相容性解决方案。本文提出了一种新型去细胞化方法,并在大鼠心脏上进行了测试,以减少使这些器官脱细胞所需的细胞毒性去污剂的浓度和孵育时间。通过在同时灌注/浸没模式下进行蛋白酶抑制、抗氧化和兴奋-收缩解偶联,对去污剂的强烈有限暴露足以产生保存非常完好的脱细胞心脏,其细胞外基质的宏观和微观结构以及生物活性均未改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/8011801/2ccc529fc68d/ab0c00540_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/8011801/5a349e3a5a04/ab0c00540_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/8011801/781248b8bd18/ab0c00540_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/8011801/419d4f018b71/ab0c00540_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/8011801/2ccc529fc68d/ab0c00540_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/8011801/5a349e3a5a04/ab0c00540_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/8011801/781248b8bd18/ab0c00540_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/8011801/419d4f018b71/ab0c00540_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/8011801/2ccc529fc68d/ab0c00540_0004.jpg

相似文献

1
RegenHeart: A Time-Effective, Low-Concentration, Detergent-Based Method Aiming for Conservative Decellularization of the Whole Heart Organ.再生心脏:一种旨在对整个心脏器官进行保守去细胞化处理的省时、低浓度、基于去污剂的方法。
ACS Biomater Sci Eng. 2020 Oct 12;6(10):5493-5506. doi: 10.1021/acsbiomaterials.0c00540. Epub 2020 Sep 10.
2
Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale.人肺和猪肺的灌注去细胞化:将基质扩大至临床规模
J Heart Lung Transplant. 2014 Mar;33(3):298-308. doi: 10.1016/j.healun.2013.10.030. Epub 2013 Oct 26.
3
Targeted proteomics effectively quantifies differences between native lung and detergent-decellularized lung extracellular matrices.靶向蛋白质组学有效地量化了天然肺与去垢剂脱细胞肺细胞外基质之间的差异。
Acta Biomater. 2016 Dec;46:91-100. doi: 10.1016/j.actbio.2016.09.043. Epub 2016 Sep 29.
4
Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts.用于猪全肝和全肾灌注去细胞化的方法,以用作临床规模生物工程移植物的支架。
Xenotransplantation. 2015 Jan-Feb;22(1):48-61. doi: 10.1111/xen.12141. Epub 2014 Oct 7.
5
In-Lab Manufacturing of Decellularized Rat Renal Scaffold for Kidney Bioengineering.用于肾脏生物工程的去细胞大鼠肾脏支架的实验室制造
Methods Mol Biol. 2018;1577:103-110. doi: 10.1007/7651_2017_96.
6
Extracellular Matrix from Whole Porcine Heart Decellularization for Cardiac Tissue Engineering.用于心脏组织工程的全猪心脏脱细胞化细胞外基质
Methods Mol Biol. 2018;1577:95-102. doi: 10.1007/7651_2017_31.
7
Perfusion decellularization of whole organs.全器官灌流去细胞化。
Nat Protoc. 2014;9(6):1451-68. doi: 10.1038/nprot.2014.097. Epub 2014 May 29.
8
Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system.使用高通量系统对猪肾脏进行脱细胞处理,用于整个器官工程。
Biomaterials. 2012 Nov;33(31):7756-64. doi: 10.1016/j.biomaterials.2012.07.023. Epub 2012 Jul 28.
9
Fast, robust and effective decellularization of whole human livers using mild detergents and pressure controlled perfusion.使用温和的清洁剂和压力控制灌注快速、稳健且有效地去除整个人类肝脏的细胞。
Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110200. doi: 10.1016/j.msec.2019.110200. Epub 2019 Sep 12.
10
Hearts beating through decellularized scaffolds: whole-organ engineering for cardiac regeneration and transplantation.去细胞支架中的心脏跳动:用于心脏再生和移植的全器官工程。
Crit Rev Biotechnol. 2016 Aug;36(4):705-15. doi: 10.3109/07388551.2015.1007495. Epub 2015 Mar 5.

引用本文的文献

1
Cardiac Tissue Engineering for Translational Cardiology: From In Vitro Models to Regenerative Therapies.用于转化心脏病学的心脏组织工程:从体外模型到再生疗法
Bioengineering (Basel). 2025 May 14;12(5):518. doi: 10.3390/bioengineering12050518.
2
Ameliorating impaired cardiac function in myocardial infarction using exosome-loaded gallic-acid-containing polyurethane scaffolds.使用负载外泌体的含没食子酸聚氨酯支架改善心肌梗死中受损的心脏功能。
Bioact Mater. 2023 Nov 24;33:324-340. doi: 10.1016/j.bioactmat.2023.11.009. eCollection 2024 Mar.
3
Recent advances in soluble decellularized extracellular matrix for heart tissue engineering and organ modeling.

本文引用的文献

1
A Comprehensive Comparison of Bovine and Porcine Decellularized Pericardia: New Insights for Surgical Applications.牛和猪脱细胞心包膜的综合比较:手术应用的新见解。
Biomolecules. 2020 Feb 28;10(3):371. doi: 10.3390/biom10030371.
2
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.缺血性和非缺血性心力衰竭中的细胞外基质。
Circ Res. 2019 Jun 21;125(1):117-146. doi: 10.1161/CIRCRESAHA.119.311148. Epub 2019 Jun 20.
3
The Biocompatibility Challenges in the Total Artificial Heart Evolution.全人工心脏演进中的生物相容性挑战。
近年来,可溶性脱细胞细胞外基质在心脏组织工程和器官建模中的应用取得了进展。
J Biomater Appl. 2023 Nov;38(5):577-604. doi: 10.1177/08853282231207216.
4
Advances in the design, generation, and application of tissue-engineered myocardial equivalents.组织工程心肌替代物在设计、生成及应用方面的进展
Front Bioeng Biotechnol. 2023 Sep 22;11:1247572. doi: 10.3389/fbioe.2023.1247572. eCollection 2023.
5
Angiogenesis and Re-endothelialization in decellularized scaffolds: Recent advances and current challenges in tissue engineering.去细胞支架中的血管生成与再内皮化:组织工程学的最新进展与当前挑战
Front Bioeng Biotechnol. 2023 Feb 16;11:1103727. doi: 10.3389/fbioe.2023.1103727. eCollection 2023.
6
Whole-Heart Tissue Engineering and Cardiac Patches: Challenges and Promises.全心脏组织工程与心脏补片:挑战与前景
Bioengineering (Basel). 2023 Jan 12;10(1):106. doi: 10.3390/bioengineering10010106.
7
Biological Scaffolds for Congenital Heart Disease.先天性心脏病的生物支架
Bioengineering (Basel). 2023 Jan 2;10(1):57. doi: 10.3390/bioengineering10010057.
8
Decellularized Extracellular Matrix Scaffolds for Cardiovascular Tissue Engineering: Current Techniques and Challenges.脱细胞细胞外基质支架在心血管组织工程中的应用:当前技术和挑战。
Int J Mol Sci. 2022 Oct 27;23(21):13040. doi: 10.3390/ijms232113040.
9
Biomaterials for Regenerative Medicine in Italy: Brief State of the Art of the Principal Research Centers.意大利再生医学用生物材料:主要研究中心的简要现状概述。
Int J Mol Sci. 2022 Jul 26;23(15):8245. doi: 10.3390/ijms23158245.
10
Decellularization for the retention of tissue niches.用于保留组织微环境的去细胞化处理。
J Tissue Eng. 2022 May 21;13:20417314221101151. doi: 10.1177/20417314221101151. eCollection 2022 Jan-Dec.
Annu Rev Biomed Eng. 2019 Jun 4;21:85-110. doi: 10.1146/annurev-bioeng-060418-052432. Epub 2019 Feb 22.
4
Preservation strategies for decellularized pericardial scaffolds for off-the-shelf availability.去细胞心包支架的保存策略,以实现即用型。
Acta Biomater. 2019 Jan 15;84:208-221. doi: 10.1016/j.actbio.2018.10.026. Epub 2018 Oct 17.
5
Mechanical Circulatory Support and Stem Cell-Based Heart Treatment in Europe-2018 Clinical Update.2018年欧洲机械循环支持与基于干细胞的心脏治疗临床进展
Artif Organs. 2018 Sep;42(9):871-878. doi: 10.1111/aor.13341.
6
Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery.用于心血管手术修复、矫正和重建的生物工程组织解决方案。
J Thorac Dis. 2018 Jul;10(Suppl 20):S2390-S2411. doi: 10.21037/jtd.2018.04.27.
7
Multimodal label-free ex vivo imaging using a dual-wavelength microscope with axial chromatic aberration compensation.采用双波长显微镜及轴向色差补偿的多模态无标记离体成像
J Biomed Opt. 2018 Mar;23(9):1-9. doi: 10.1117/1.JBO.23.9.091403.
8
The Rapidly Evolving Concept of Whole Heart Engineering.全心工程的快速发展概念
Stem Cells Int. 2017;2017:8920940. doi: 10.1155/2017/8920940. Epub 2017 Nov 9.
9
A sterilization method for decellularized xenogeneic cardiovascular scaffolds.一种去细胞化异种心血管支架的消毒方法。
Acta Biomater. 2018 Feb;67:282-294. doi: 10.1016/j.actbio.2017.11.035. Epub 2017 Dec 2.
10
The Light and Shadow of Senescence and Inflammation in Cardiovascular Pathology and Regenerative Medicine.衰老与炎症在心血管病理学和再生医学中的光影。
Mediators Inflamm. 2017;2017:7953486. doi: 10.1155/2017/7953486. Epub 2017 Oct 8.